The revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI) can be used to assess disease activity and damage. Acute cutaneous LE affects at least 50% of patients with systemic lupus erythematosus (SLE). Specific features of acute cutaneous LE may include: See more images of systemic lupus erythematosus. Plaquenil low heart rate Chloroquine blood to plasma ratio Hydroxychloroquine rheumatoid arthritis dose Plaquenil knee side effects TreatmentRisksClinical significanceContraindicationsPreventionResultsBenefitsPrognosis Plaquenil is a slow-acting drug, meaning that it can take up to 6 months to experience the full benefits of this medication, but it is possible for symptoms to improve in as few as 1 or 2 months. Plaquenil and other antimalarials are the key to controlling lupus long-term, and some lupus patients may be on Plaquenil for the rest of their lives. Hydroxychloroquine Plaquenil is used to treat malaria, lupus, and rheumatoid arthritis. Learn about side effects, warnings, dosage, and more. One-third of the cases are due to previous drug exposure. About 15% of patients with cutaneous LE have subacute cutaneous LE. Plaquenil for cutaneous lupus Subacute Cutaneous Lupus Erythematosus SCLE Medication., Plaquenil What You Need to Know - Kaleidoscope Fighting Lupus Plaquenil side effects dizzinessPlaquenil for granuloma annulareEye complications from plaquenil Plaquenil hydroxychloroquine is an antimalarial medication used to treat or prevent malaria, a disease caused by parasites, which enter the body through the bite of a mosquito. Plaquenil is also used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. Side Effects of Plaquenil Hydroxychloroquine, Warnings, Uses. Hydroxychloroquine Side Effects, Dosage, Uses, and More. What Conditions does Plaquenil Treat? - WebMD. Cutaneous lupus erythematosus, including subacute cutaneous lupus, is an autoimmune disease felt to be due to an interplay of genetics, hormones and environment. Given that lupus is more common in women of childbearing age, estrogen is felt to contribute to the disease pathogenesis. User Reviews for Plaquenil to treat Systemic Lupus Erythematosus The following information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners. The antimalarial agents chloroquine CQ and hydroxychloroquine HCQ are considered to be effective for the treatment of cutaneous lupus erythematosus CLE and the symptoms associated with systemic lupus erythematosus SLE such as rashes, joint pain, and fatigue.